Status:
COMPLETED
Yoga for Painful Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized-Controlled Study
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
Oncology Nursing Society
Conditions:
Chemotherapy-induced Peripheral Neuropathy
Yoga
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study will examine the feasibility of conducting an eight-week yoga intervention for individuals with chronic painful chemotherapy-induced peripheral neuropathy.
Detailed Description
This research study will examine the feasibility of conducting an eight-week yoga intervention for individuals with chronic painful chemotherapy-induced peripheral neuropathy. The investigators will a...
Eligibility Criteria
Inclusion
- ≥18 years of age,
- self-report ≥ 4/10 worst chemotherapy-induced peripheral neuropathy pain over the past week,
- at least three months post neurotoxic chemotherapy completion
- signed informed consent,
- willingness to participate in all study activities
- speak/read English
Exclusion
- prognosis of less than three months,
- documented peripheral neuropathy due to other causes (e.g., diabetes),
- planned receipt of neurotoxic chemotherapy during the study period,
- practice yoga \>45 minutes per week over the past six months,
- diagnosis or documented recent history of significant psychiatric comorbidity (i.e., psychosis, suicidal ideation, or substance abuse)
- clinician deems that the patient is physically/functionally unable to participate in a yoga program
Key Trial Info
Start Date :
August 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 18 2021
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT03824860
Start Date
August 6 2019
End Date
February 18 2021
Last Update
March 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215